VC-backed OpGen files for IPO
OpGen Inc has filed for an IPO. The number of shares that will be sold as well as its pricing terms have yet to be set. The company plans on listing its stock on the NASDAQ under the ticker symbol "OPGN." Maxim Group LLC is serving as sole underwriter. Based in Gaithersburg, Maryland, OpGen is a molecular diagnostics company. OpGen's backers include CHL Medical Partners, Highland Capital Partners, Mason Wells Biomedical and Versant Ventures.
4 March 2015•2 mins read
